US Patent Issued to BiSiChem on July 22 for "Fused ring heteroaryl compounds as RIPK1 inhibitors" (South Korean Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,695, issued on July 22, was assigned to BiSiChem Co. Ltd. (Geonggi-Do, South Korea).

"Fused ring heteroaryl compounds as RIPK1 inhibitors" was invented by Cheolhwan Yoon (Gyeonggi-Do, South Korea), Jonghwan Bae (Gyeonggi-Do, South Korea), Namhee Kim (Gyeonggi-Do, South Korea), Cheolkyu Han (Gyeonggi-Do, South Korea) and Jeongbeob Seo (Gyeonggi-Do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides novel substituted heterocyclic compounds represented by Formula I, or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer or prodrug thereof, and a composition comprising these compounds. The compounds pro...